Abstract
Inositol hexaphosphate (IP6, InsP6) is a polyphosphorylated carbohydrate with diverse signaling properties. IP6 is plentiful in organisms as diverse as yeast, actinobacteria, mammals and plants. In the plant kingdom, IP6 accumulates during seed development; during germination it is broken down into lower inositol phosphates and micronutrients to maintain seedling. IP6 is the most abundant of the intracellular inositol phosphates in eukaryotes. In mammals IP6 maintains homeostasis, stores phosphate and acts as a strong anti-oxidant and neurotransmitter. IP6’s rapid phosphate turnover properties justify its critical role in cellular pathways involved in signal transduction, control of cell proliferation and differentiation, RNA export, DNA repair, energy transduction and ATP regeneration. The health benefits of IP6 have been demonstrated to lower serum cholesterol level, normalize pathological platelet activity and prevent pathological calcification and kidney stone formation. It is also a potent antioxidant and immunity enhancer. However, it is the field of cancer prevention and therapy that may be the biggest career for IP6. In this review we present updated knowledge on signaling events caused by this fascinating, ubiquitous molecule that has numerous functions.
Keywords: IP6, inositol, phytate, polyphosphates, signal transduction, nutraceuticals, actinobacteria, myo-isoform, pentakisphosphate, Myxobacteria
Current Signal Transduction Therapy
Title:IP6 (Inositol Hexaphosphate) as a Signaling Molecule
Volume: 7 Issue: 3
Author(s): Abul Kalam Shamsuddin and Sanchita Bose
Affiliation:
Keywords: IP6, inositol, phytate, polyphosphates, signal transduction, nutraceuticals, actinobacteria, myo-isoform, pentakisphosphate, Myxobacteria
Abstract: Inositol hexaphosphate (IP6, InsP6) is a polyphosphorylated carbohydrate with diverse signaling properties. IP6 is plentiful in organisms as diverse as yeast, actinobacteria, mammals and plants. In the plant kingdom, IP6 accumulates during seed development; during germination it is broken down into lower inositol phosphates and micronutrients to maintain seedling. IP6 is the most abundant of the intracellular inositol phosphates in eukaryotes. In mammals IP6 maintains homeostasis, stores phosphate and acts as a strong anti-oxidant and neurotransmitter. IP6’s rapid phosphate turnover properties justify its critical role in cellular pathways involved in signal transduction, control of cell proliferation and differentiation, RNA export, DNA repair, energy transduction and ATP regeneration. The health benefits of IP6 have been demonstrated to lower serum cholesterol level, normalize pathological platelet activity and prevent pathological calcification and kidney stone formation. It is also a potent antioxidant and immunity enhancer. However, it is the field of cancer prevention and therapy that may be the biggest career for IP6. In this review we present updated knowledge on signaling events caused by this fascinating, ubiquitous molecule that has numerous functions.
Export Options
About this article
Cite this article as:
Kalam Shamsuddin Abul and Bose Sanchita, IP6 (Inositol Hexaphosphate) as a Signaling Molecule, Current Signal Transduction Therapy 2012; 7 (3) . https://dx.doi.org/10.2174/157436212802481628
DOI https://dx.doi.org/10.2174/157436212802481628 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antioxidants and Neuroprotection in the Adult and Developing Central Nervous System
Current Medicinal Chemistry Immunotherapy in Liver Diseases: A Balance Between Immunity and Tolerance
Current Drug Metabolism A Non-Steroidal Anti-Inflammatory Agent Provides Significant Protection During Focal Ischemic Stroke with Decreased Expression of Matrix Metalloproteinases
Current Neurovascular Research Dynamics of Toll-like Receptors Signaling in Skeletal Muscle Atrophy
Current Medicinal Chemistry Annexin A5 Imaging: An Academic Research – Clinical Trials and Theses
Current Molecular Imaging (Discontinued) Endothelial Dysfunction: The Link Between Homocysteine and Hydrogen Sulfide
Current Medicinal Chemistry Green Tea Polyphenols as an Anti-Oxidant and Anti-Inflammatory Agent for Cardiovascular Protection
Cardiovascular & Hematological Disorders-Drug Targets Hydrogen Sulfide in Diabetic Complications: Focus on Molecular Mechanisms
Endocrine, Metabolic & Immune Disorders - Drug Targets Does Caffeine Affect Cardiovascular Responses?
Vascular Disease Prevention (Discontinued) Brief Daily Episode of Normoxia Inhibits Cardioprotection Conferred by Chronic Continuous Hypoxia. Role of Oxidative Stress and BK<sub>Ca</sub> Channels
Current Pharmaceutical Design Oxidative Stress Induced Mitochondrial DNA Deletion as a Hallmark forthe Drug Development in the Context of the Cerebrovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Subject Index Volume 2
Current Pediatric Reviews Cell-Penetrating Peptide Technology to Deliver Chaperones and Associated Factors in Diseases and Basic Research
Current Pharmaceutical Biotechnology Appraisal of Nano-Lipidic Astaxanthin cum Thermoreversible Gel and its Efficacy in Haloperidol Induced Parkinsonism
Current Drug Delivery Key Role of Mitochondria in Alzheimer’s Disease Synaptic Dysfunction
Current Pharmaceutical Design Saving the Ischemic Penumbra: Potential Role for Statins and Phosphodiesterase Inhibitors
Current Vascular Pharmacology Protein Kinase C – Possible Therapeutic Target to Treat Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Furocoumarins from Cnidium monnieri Act as Peroxisome Proliferatoractivated R and Farnesoid X Receptor Agonists
Mini-Reviews in Organic Chemistry A1 Adenosine Receptor Agonists: Medicinal Chemistry and Therapeutic Potential
Current Pharmaceutical Design Potential Genetic Therapies for Acute Lung Injury
Current Gene Therapy